PL2904403T3 - Sposób rozpoznawania lub monitorowania funkcji nerki lub rozpoznawania dysfunkcji nerki - Google Patents

Sposób rozpoznawania lub monitorowania funkcji nerki lub rozpoznawania dysfunkcji nerki

Info

Publication number
PL2904403T3
PL2904403T3 PL13776750T PL13776750T PL2904403T3 PL 2904403 T3 PL2904403 T3 PL 2904403T3 PL 13776750 T PL13776750 T PL 13776750T PL 13776750 T PL13776750 T PL 13776750T PL 2904403 T3 PL2904403 T3 PL 2904403T3
Authority
PL
Poland
Prior art keywords
diagnosing
kidney
monitoring
dysfunction
function
Prior art date
Application number
PL13776750T
Other languages
English (en)
Inventor
Andreas Bergmann
Original Assignee
Sphingotec Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sphingotec Gmbh filed Critical Sphingotec Gmbh
Publication of PL2904403T3 publication Critical patent/PL2904403T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/563—Immunoassay; Biospecific binding assay; Materials therefor involving antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/665—Assays involving proteins derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • G01N2333/70—Enkephalins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
PL13776750T 2012-10-02 2013-10-01 Sposób rozpoznawania lub monitorowania funkcji nerki lub rozpoznawania dysfunkcji nerki PL2904403T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP12187051 2012-10-02
EP13170327 2013-06-03
EP13776750.5A EP2904403B1 (en) 2012-10-02 2013-10-01 A method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction
PCT/EP2013/070470 WO2014053501A1 (en) 2012-10-02 2013-10-01 A method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction

Publications (1)

Publication Number Publication Date
PL2904403T3 true PL2904403T3 (pl) 2018-08-31

Family

ID=49356398

Family Applications (2)

Application Number Title Priority Date Filing Date
PL18164302T PL3361260T3 (pl) 2012-10-02 2013-10-01 Sposób diagnozowania lub monitorowania czynności nerek lub diagnozowania dysfunkcji nerek
PL13776750T PL2904403T3 (pl) 2012-10-02 2013-10-01 Sposób rozpoznawania lub monitorowania funkcji nerki lub rozpoznawania dysfunkcji nerki

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL18164302T PL3361260T3 (pl) 2012-10-02 2013-10-01 Sposób diagnozowania lub monitorowania czynności nerek lub diagnozowania dysfunkcji nerek

Country Status (11)

Country Link
US (4) US9664695B2 (pl)
EP (2) EP2904403B1 (pl)
JP (2) JP6307509B2 (pl)
CN (1) CN104769433B (pl)
CA (1) CA2886779C (pl)
DK (2) DK2904403T3 (pl)
ES (2) ES2810001T3 (pl)
PL (2) PL3361260T3 (pl)
RU (2) RU2679913C2 (pl)
TR (1) TR201809001T4 (pl)
WO (1) WO2014053501A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2906578B8 (en) * 2012-10-11 2019-06-26 Armaron Bio Pty Ltd Novel flavonoid compounds and uses thereof
ES3075629T3 (en) * 2015-04-24 2026-08-06 Sphingotec Gmbh A method for predicting the risk of incidence of chronic kidney disease
JP7123329B2 (ja) * 2016-05-17 2022-08-23 国立大学法人大阪大学 腎臓病の予後予測方法及びシステム
RU2653817C1 (ru) * 2016-11-23 2018-05-14 федеральное государственное бюджетное образовательное учреждение высшего образования "Ульяновский государственный университет" Способ прогнозирования острого повреждения почек у больных с инсультом
RU2019144031A (ru) 2017-05-30 2021-06-30 Сфинготек Гмбх Способ диагностики или мониторинга функции почек или диагностики дисфункции почек
US20220291234A1 (en) * 2019-08-15 2022-09-15 Sphingotec Gmbh A method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction in pediatric patients
RU2753588C1 (ru) * 2020-10-05 2021-08-18 Федеральное государственное бюджетное образовательное учреждение высшего образования "Оренбургский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ диагностики доклинической стадии вторичных нефропатий у детей
RU2767701C1 (ru) * 2020-12-16 2022-03-18 Надежда Владимировна Агранович Способ ранней диагностики эндотелиальной дисфункции почек у больных хронической обструктивной болезнью легких
WO2025229075A1 (en) 2024-05-03 2025-11-06 Sphingotec Gmbh A method for the specific determination of proenkephalin fragment 119-159

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU634716B2 (en) 1988-08-01 1993-03-04 Ciba Corning Diagnostics Corp. Method for detection of an analyte using acridinium esters and liposomes
US6818418B1 (en) 1998-12-10 2004-11-16 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
CN1628126A (zh) 2001-08-30 2005-06-15 比奥雷克西斯药物公司 经修饰的运铁蛋白融合蛋白
US20040014143A1 (en) * 2002-05-29 2004-01-22 Haskins William E. Method and apparatus for detecting and monitoring peptides, and peptides identified therewith
PT2298278E (pt) 2002-06-07 2016-02-25 Dyax Corp Prevenção e redução da perda de sangue e resposta inflamatória
CA2543360A1 (en) 2003-10-24 2005-05-06 Joost A. Kolkman Ldl receptor class a and egf domain monomers and multimers
US20100028995A1 (en) 2004-02-23 2010-02-04 Anaphore, Inc. Tetranectin Trimerizing Polypeptides
EP2293079B1 (en) 2004-05-13 2013-08-14 B.R.A.H.M.S GmbH Use of precursors of enkephalins and/or their fragments in medical diagnostics
AU2005287557B2 (en) 2004-09-21 2011-10-13 Biontech Ag Use of microproteins as tryptase inhibitors
EP2137538B1 (en) * 2007-03-21 2014-04-09 Bioporto Diagnostics A/s Diagnostic test for renal injury
ES2373832T3 (es) 2007-12-19 2012-02-09 Affibody Ab Polipéptido derivado de proteína a y capaz de unirse a pdgf.
NZ592591A (en) 2008-11-03 2012-04-27 Molecular Partners Ag Binding proteins comprising ankyrin repeast domains that inhibit the vegf-a receptor interaction
US9476880B2 (en) * 2008-11-21 2016-10-25 Future Medical Diagnostics Co., Ltd. Methods, devices and kits for detecting or monitoring acute kidney injury
CA2772162C (en) 2009-08-27 2018-05-22 Covagen Ag Anti-il-17a fynomers and medical uses thereof
BR112012014417B1 (pt) 2009-12-14 2021-11-09 Scil Proteins Gmbh Proteínas ubiquitinas modificadas tendo uma atividade de ligação específica para o extradomínio b de fibronectina
AU2011263786B2 (en) 2010-06-08 2014-11-13 Astrazeneca Ab Tear lipocalin muteins binding IL-4 R alpha
JP5899213B2 (ja) 2010-08-06 2016-04-06 マイカーティス エヌ.ヴェ.MyCartis NV 腎機能不全のバイオマーカーとしてのパールカン
CN102636652A (zh) * 2012-04-18 2012-08-15 苏州大学 尿液中可溶性Corin在慢性肾病诊断中的应用

Also Published As

Publication number Publication date
ES2674822T3 (es) 2018-07-04
EP2904403B1 (en) 2018-03-28
US11016107B2 (en) 2021-05-25
EP3361260A1 (en) 2018-08-15
EP2904403A1 (en) 2015-08-12
RU2679913C2 (ru) 2019-02-14
EP3361260B1 (en) 2020-06-10
US9664695B2 (en) 2017-05-30
JP6307509B2 (ja) 2018-04-04
US20210333292A1 (en) 2021-10-28
CN104769433B (zh) 2018-07-27
CA2886779A1 (en) 2014-04-10
RU2707303C1 (ru) 2019-11-26
WO2014053501A1 (en) 2014-04-10
US12399186B2 (en) 2025-08-26
DK2904403T3 (en) 2018-07-16
US10114029B2 (en) 2018-10-30
CA2886779C (en) 2022-11-01
US20190049470A1 (en) 2019-02-14
RU2015116674A (ru) 2016-11-27
US20170261522A1 (en) 2017-09-14
ES2810001T3 (es) 2021-03-08
PL3361260T3 (pl) 2020-12-14
JP2018141788A (ja) 2018-09-13
JP2015535936A (ja) 2015-12-17
CN104769433A (zh) 2015-07-08
DK3361260T3 (da) 2020-08-03
TR201809001T4 (tr) 2018-07-23
JP6669794B2 (ja) 2020-03-18
HK1212436A1 (en) 2016-06-10
US20150260732A1 (en) 2015-09-17

Similar Documents

Publication Publication Date Title
GB2505324B (en) A monitoring system
GB201112161D0 (en) Portal monitoring
GB2491983B (en) Vibration monitoring
PL2778697T3 (pl) System monitorowania stanu akumulatora
EP2780544A4 (en) DETERMINATION OF OPTIMAL PARAMETERS FOR A BOHRLOCHOPERATION
GB2488515B (en) A test system
GB2520670B (en) A system for monitoring a remote underwater location
GB201411337D0 (en) Seismic monitoring
EP2752834A4 (en) DEVICE FOR MONITORING THE VEHICLE ENVIRONMENT
PT2901370T (pt) Processo de detecção de uma face real
EP2726835A4 (en) VIBRATION MONITORING SYSTEM
SG11201401045TA (en) Electrochemical desalination for oil recovery
GB2503610B (en) Method for monitoring seafloor movements
ZA201308885B (en) Method for automatic mutual alternation between pumps
PL3361260T3 (pl) Sposób diagnozowania lub monitorowania czynności nerek lub diagnozowania dysfunkcji nerek
IL232355A0 (en) A method for determining calcification tendency
SG2012068490A (en) A relay for automatically selecting a monitoring range
HUE037404T2 (hu) Eljárás csõ gyártására
GB2493946B (en) Crane monitoring system
PL2691015T3 (pl) System monitorowania
GB201116299D0 (en) Condition monitoring employing cross-correlation
GB201203110D0 (en) A filter for a pipe
GB2508750B (en) A monitoring system
GB2517558B (en) Method for monitoring an underwater site
GB201208510D0 (en) Apparatus for monitoring an offshore construction area